Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -337,842 | -138,959 | -559,017 | -388,128 | -278,813 |
| Depreciation Amortization | 312,543 | 43,178 | 165,834 | 93,079 | 57,969 |
| Income taxes - deferred | -50,907 | -4 | -34,276 | N/A | N/A |
| Accounts receivable | -18,022 | -43,426 | -48,468 | -24,773 | -29,549 |
| Other Working Capital | 71,101 | 38,715 | -94,935 | -64,248 | -27,292 |
| Other Operating Activity | -20,484 | 71,005 | 214,208 | 193,379 | 125,039 |
| Operating Cash Flow | $-43,611 | $-29,491 | $-356,654 | $-190,691 | $-152,646 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 10,228 | 14,696 | 465,428 | 383,205 | 220,735 |
| PPE Investments | -16,515 | -10,270 | -32,016 | -23,394 | -18,012 |
| Net Acquisitions | -46,436 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | N/A | N/A | -22,787 | N/A | N/A |
| Purchase Sale Intangibles | N/A | -33,397 | -120,444 | -102,069 | -81,426 |
| Other Investing Activity | 0 | -33,397 | -120,444 | -102,069 | -81,426 |
| Investing Cash Flow | $-52,723 | $-28,971 | $290,181 | $257,742 | $121,297 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 300,000 | N/A | N/A |
| Debt Repayment | -1,379 | -1,379 | -151,276 | -151,276 | -1,276 |
| Common Stock Issued | 24,130 | 5,655 | 71,082 | 16,310 | 6,305 |
| Other Financing Activity | -197 | -182 | -51,854 | 0 | 0 |
| Financing Cash Flow | $22,554 | $4,094 | $167,952 | $-134,966 | $5,029 |
| Exchange Rate Effect | 2,351 | -7,963 | -2,772 | -8,792 | 3,347 |
| Beginning Cash Position | 295,925 | 295,925 | 197,218 | 197,218 | 197,218 |
| End Cash Position | 224,496 | 233,594 | 295,925 | 120,511 | 174,245 |
| Net Cash Flow | $-71,429 | $-62,331 | $98,707 | $-76,707 | $-22,973 |
| Free Cash Flow | |||||
| Operating Cash Flow | -43,611 | -29,491 | -356,654 | -190,691 | -152,646 |
| Capital Expenditure | -16,515 | -10,270 | -32,016 | -23,394 | -18,012 |
| Free Cash Flow | -60,126 | -39,761 | -388,670 | -214,085 | -170,658 |